AbbVie Inc (NYSE: ABBV)
DRUGS - Drug Manufacturers - Major
Health Care
Stock price data as of
Closing price: $295.03
-
Support level$276.30
-
Resistance levelN/A
-
Beta0.3
-
RSI (14-day)59.9
- ABBV is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- Volatility is forecast to fall over the next month.
- Price broke above prior resistance level - a short-term bullish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $197.38 | $295.03 | 100.0% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $240.79 | $275.51 | $289.65 | $292.09 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week6.0%
-
In the next month13.6%
-
In the next year50.6%
| Period | Value |
|---|---|
| Historical (5 year) | 23.5% |
| Last month | 22.7% |
| Current estimate | 21.9% |
| Next month forecast | 24.0% |